Tumour-associated antigens CEA, CA125, SCC and TPS in gynaecological cancer.
Pretreatment values of CEA, CA125, SCC and TPS were measured in 130 women with 1) ovarian carcinoma (n = 25), 2) breast cancer (n = 20), 3) endometrial cancer (n = 14), 4) cervical squamous cell carcinoma (n = 20), 5) cervical adenocarcinoma (n = 9) and 6) benign gynaecological diseases (n = 42) in order to evaluate the usefulness of multiple markers in diagnosing and monitoring patients with gynaecological cancer. Antigen values were significantly higher in the cancer groups than those in the benign one (p < 0.0001). CEA values were significantly elevated in the 2nd and 5th groups, CA125 in the 1st and 5th, SCC in the 4th and 5th, and TPS in the 1st, 2nd and 5th compared to the remaining groups (p < 0.04-p < 0.0001). In advanced stage diseases, significantly higher antigen values, except for SCC, than those in limited tumours were measured (p < 0.05-p < 0.0001). In conclusion, our results suggest that, multiple markers may be more efficient than the use of single markers in accurately identifying malignant from benign gynaecological diseases and in monitoring cancer patients.
Sarandakou
A
A
2nd Dept. of Obstetrics and Gynaecology of Athens University, Areteion University Hospital, Greece.
Phocas
I
I
Botsis
D
D
Sikiotis
K
K
Rizos
D
D
Kalambokis
D
D
Trakakis
E
E
Chryssikopoulos
A
A
D000230:Adenocarcinoma / Q000175:diagnosis / Q000276:immunology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000276:immunology; D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000276:immunology; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis* / Q000276:immunology*; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000276:immunology
D015295:Antigens, Tumor-Associated, Carbohydrate